ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $108,754,455 | +19.2% | 221,212 | -5.5% | 0.02% | +29.4% |
Q2 2023 | $91,218,255 | -5.2% | 234,055 | -9.4% | 0.02% | -10.5% |
Q1 2023 | $96,228,472 | +15.1% | 258,276 | +17.0% | 0.02% | +11.8% |
Q4 2022 | $83,596,037 | +9.8% | 220,669 | +2.4% | 0.02% | +6.2% |
Q3 2022 | $76,115,000 | +286.4% | 215,593 | +314.7% | 0.02% | +300.0% |
Q2 2022 | $19,696,000 | -73.8% | 51,985 | -78.2% | 0.00% | -69.2% |
Q1 2022 | $75,205,000 | -46.2% | 238,511 | -40.2% | 0.01% | -40.9% |
Q4 2021 | $139,735,000 | -30.8% | 399,028 | -40.3% | 0.02% | -35.3% |
Q3 2021 | $201,945,000 | +20.1% | 668,696 | +19.8% | 0.03% | +21.4% |
Q2 2021 | $168,100,000 | +17.7% | 558,347 | +7.7% | 0.03% | +12.0% |
Q1 2021 | $142,766,000 | -21.3% | 518,413 | -15.9% | 0.02% | -24.2% |
Q4 2020 | $181,299,000 | -34.9% | 616,475 | -41.9% | 0.03% | -43.1% |
Q3 2020 | $278,364,000 | +93.7% | 1,060,354 | +66.2% | 0.06% | +81.2% |
Q2 2020 | $143,726,000 | +58.5% | 638,131 | -7.3% | 0.03% | +33.3% |
Q1 2020 | $90,701,000 | +78.7% | 688,542 | +117.8% | 0.02% | +118.2% |
Q4 2019 | $50,742,000 | – | 316,106 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |